Tradestie Institutional Equity Comparison Engine

OBAI vs LNAI โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

LNAI Overall Edge

LNAI Captures Institutional Edge (2โ€“1 Pillars ยท 6โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Lunai Bioworks Inc. Common Stock (LNAI) driven by superior Growth & Margin, Momentum & Technical while OBAI counters with relative strength in Options & Structure. Fundamentally, OBAI trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus LNAI at N/M Forward P/E and -6888.6% operating margin (+0.0% YoY). In options structure, OBAI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against LNAI sits in UNCLASSIFIED (50th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
OBAI N/M vs LNAI N/M Fwd P/E
Growth & Margin Winner LNAI
Op Margin N/A vs -6888.6% ยท YoY N/A vs +0.0%
Momentum & Technical Winner LNAI
1Y -95.2% vs -84.2% ยท 52W Pos 4% vs 0%
Options & Structure Winner OBAI
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (50th %ile IV)
OBAI US Equity
OBAI
Institutional Equity
$1.59
-3.64% 1D
Market Cap N/A
1M Return +1034.9%
1Y Return -95.18%
Forward P/E N/M
Unified AI Score
42.0 / 100 HOLD
Tech 30.0 Fund 35.0 Flow 50.0 Mom 40.0
LNAI NASDAQ
Lunai Bioworks Inc. Common Stock
Pharmaceutical Preparations
$0.16
-30.2% 1D
Market Cap $1.2M
1M Return -88.79%
1Y Return -84.15%
Forward P/E N/M
Unified AI Score
44.1 / 100 HOLD
Tech 45.0 Fund 43.0 Flow 43.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: OBAI -95.18% LNAI -84.15% Spread: +17.73 pp (LNAI Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
OBAI TTM Op. Margin: N/A LNAI TTM Op. Margin: -6888.6%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on OBAI vs LNAI. Trailing 12-month operating profitability (OBAI N/A vs LNAI -6888.6%) and valuation multiples (OBAI N/M vs LNAI N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: OBAI (2) vs LNAI (6)
Institutional Metric OBAI LNAI Criterion Row Winner
Market Capitalization Scale N/A $1.2M Larger Scale LNAI
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A +0.0% Higher Growth LNAI
Operating Margin (TTM) Profitability N/A -6888.6% Higher Margin LNAI
Net Profit Margin Profitability N/A 0.0% Higher Margin LNAI
Return on Equity (ROE) Capital Efficiency N/A -325.5% Higher ROE LNAI
52-Week Range Position Momentum 4% ($0โ€“$38) 0% ($0โ€“$5) Stronger Trend OBAI
Beta / 30D Volatility Risk Regime 5.81ฮฒ ยท 117% Vol 3.92ฮฒ ยท 186% Vol Lower Realized Risk OBAI
Unified Institutional Score Composite Signal 42.0 / 100 (HOLD) 44.1 / 100 (HOLD) Higher Composite LNAI

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full OBAI vs LNAI Buy Guide
OBAI UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live OBAI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
LNAI UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 50th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live LNAI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither OBAI nor LNAI registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.